Published in Int J Oncol on May 27, 2013
MiR-200, a new star miRNA in human cancer. Cancer Lett (2013) 1.50
The Regulatory Role of MicroRNAs in EMT and Cancer. J Oncol (2015) 1.22
miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma. PLoS One (2014) 1.15
EGFR-TKI resistance in NSCLC patients: mechanisms and strategies. Am J Cancer Res (2014) 1.08
miR-148b functions as a tumor suppressor in non-small cell lung cancer by targeting carcinoembryonic antigen (CEA). Int J Clin Exp Med (2014) 1.07
miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25. Mol Cancer (2014) 1.05
The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers. Oncogene (2015) 1.01
miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family. J Transl Med (2014) 0.95
MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1. J Exp Clin Cancer Res (2015) 0.89
Therapeutic use of microRNAs in lung cancer. Biomed Res Int (2014) 0.87
Interleukin-23 promotes the epithelial-mesenchymal transition of oesophageal carcinoma cells via the Wnt/β-catenin pathway. Sci Rep (2015) 0.86
Overexpression of secretagogin inhibits cell apoptosis and induces chemoresistance in small cell lung cancer under the regulation of miR-494. Oncotarget (2014) 0.84
Metadherin regulates proliferation and metastasis via actin cytoskeletal remodelling in non-small cell lung cancer. Br J Cancer (2014) 0.84
MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer. J Ovarian Res (2015) 0.83
Decreased expression of the chromatin remodeler ATRX associates with melanoma progression. J Invest Dermatol (2014) 0.82
Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene. Mol Diagn Ther (2014) 0.79
MicroRNA signature characterizes primary tumors that metastasize in an esophageal adenocarcinoma rat model. PLoS One (2015) 0.79
MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy. BMC Cancer (2015) 0.78
miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition. Front Pharmacol (2016) 0.77
MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancer. Oncotarget (2016) 0.77
microRNA-664 enhances proliferation, migration and invasion of lung cancer cells. Exp Ther Med (2017) 0.76
The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression. Int J Mol Sci (2016) 0.76
Systematic enrichment analysis of microRNA expression profiling studies in endometriosis. Iran J Basic Med Sci (2015) 0.76
Thrombospondin-1 and microRNA-1 expression in response to multiwalled carbon nanotubes in alveolar epithelial cells. Environ Toxicol (2017) 0.75
Non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer. Oncotarget (2017) 0.75
Genetic variants in regulatory regions of microRNAs are associated with lung cancer risk. Oncotarget (2016) 0.75
Direct targeting of MAPK8IP1 by miR-10a-5p is a major mechanism for gastric cancer metastasis. Oncol Lett (2016) 0.75
Members of the microRNA-200 family are promising therapeutic targets in cancer. Exp Ther Med (2017) 0.75
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 96.87
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Combinatorial microRNA target predictions. Nat Genet (2005) 50.48
Epithelial-mesenchymal transitions in development and disease. Cell (2009) 39.17
miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res (2010) 25.85
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol (2008) 24.27
The microRNA.org resource: targets and expression. Nucleic Acids Res (2007) 16.26
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev (2008) 15.01
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep (2008) 10.71
microRNAs as oncogenes and tumor suppressors. Dev Biol (2006) 10.68
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med (2008) 10.12
MicroRNA signatures in human ovarian cancer. Cancer Res (2007) 9.45
A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res (2008) 7.45
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology (2006) 7.06
The database of experimentally supported targets: a functional update of TarBase. Nucleic Acids Res (2008) 5.65
MicroRNAs--the micro steering wheel of tumour metastases. Nat Rev Cancer (2009) 5.47
The role of epithelial-mesenchymal transition in cancer pathology. Pathology (2007) 5.16
Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer (2011) 5.12
MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle (2008) 4.81
Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet (2006) 4.34
Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res (2006) 4.11
Lung cancer. Lancet (2000) 3.93
Formation, regulation and evolution of Caenorhabditis elegans 3'UTRs. Nature (2010) 3.87
p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol (2011) 3.85
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med (2011) 3.82
p53 enters the microRNA world. Cancer Cell (2007) 3.78
Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev (2009) 3.58
MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res (2009) 3.05
miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One (2009) 2.97
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med (2011) 2.93
Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res (1998) 2.59
Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res (2009) 2.50
Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res (2006) 2.47
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev (2009) 2.41
Prognostic Values of microRNAs in Colorectal Cancer. Biomark Insights (2006) 2.35
Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg (1988) 2.09
DLC-1:a Rho GTPase-activating protein and tumour suppressor. J Cell Mol Med (2007) 2.09
Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res (2010) 2.04
RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. Cancer Res (2004) 1.84
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers. J Oncol (2009) 1.84
Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells. Cancer Res (2010) 1.75
Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma. Clin Cancer Res (2006) 1.55
miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. Mol Cancer Res (2010) 1.54
MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. PLoS One (2010) 1.50
Confirmation of gene expression-based prediction of survival in non-small cell lung cancer. Clin Cancer Res (2008) 1.49
Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells. Cancer Lett (2010) 1.47
Cancer stemness and metastasis: therapeutic consequences and perspectives. Eur J Cancer (2010) 1.47
β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells. Cancer Res (2011) 1.33
miRNAs as molecular biomarkers of cancer. Expert Rev Mol Diagn (2010) 1.28
Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer. Am J Respir Crit Care Med (1998) 1.23
Hybrid models identified a 12-gene signature for lung cancer prognosis and chemoresponse prediction. PLoS One (2010) 1.17
Expression and polarized localization of the hemochromatosis gene product HFE in retinal pigment epithelium. Invest Ophthalmol Vis Sci (2006) 1.10
MicroRNA silencing of tumor suppressor DLC-1 promotes efficient hepatitis C virus replication in primary human hepatocytes. Hepatology (2010) 1.07
Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues. BMC Cancer (2010) 1.05
MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases. J Cardiovasc Transl Res (2010) 1.04
Updates in non-small cell lung cancer--insights from the 2009 45th annual meeting of the American Society of Clinical Oncology. J Hematol Oncol (2010) 0.94
Dysregulated expression of dicer and drosha in breast cancer. Pathol Oncol Res (2011) 0.94
p53 Spreads out further: suppression of EMT and stemness by activating miR-200c expression. Cell Res (2011) 0.92
Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer. Lung Cancer (2008) 0.86
HFE polymorphisms influence the response to chemotherapeutic agents via induction of p16INK4A. Int J Cancer (2011) 0.86
miR-802 regulates human angiotensin II type 1 receptor expression in intestinal epithelial C2BBe1 cells. Am J Physiol Gastrointest Liver Physiol (2010) 0.81
Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol (2005) 7.28
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol (2005) 6.04
Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material. J Toxicol Environ Health A (2004) 3.96
Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology (2009) 3.52
Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A (2003) 2.82
Evaluating the toxicity of airborne particulate matter and nanoparticles by measuring oxidative stress potential--a workshop report and consensus statement. Inhal Toxicol (2008) 2.53
Systemic microvascular dysfunction and inflammation after pulmonary particulate matter exposure. Environ Health Perspect (2006) 2.38
Uncovering early response of gene regulatory networks in ESCs by systematic induction of transcription factors. Cell Stem Cell (2009) 2.32
MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res (2007) 2.08
Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes. Part Fibre Toxicol (2011) 2.08
Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part Fibre Toxicol (2010) 2.05
Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity. J Biol Chem (2006) 1.78
Quantitative techniques for assessing and controlling the dispersion and biological effects of multiwalled carbon nanotubes in mammalian tissue culture cells. ACS Nano (2010) 1.78
Particulate matter exposure impairs systemic microvascular endothelium-dependent dilation. Environ Health Perspect (2004) 1.77
Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. ACS Nano (2011) 1.75
Transcriptome analysis of mouse stem cells and early embryos. PLoS Biol (2003) 1.75
Surface area of particle administered versus mass in determining the pulmonary toxicity of ultrafine and fine carbon black: comparison to ultrafine titanium dioxide. Part Fibre Toxicol (2009) 1.74
Dispersal state of multiwalled carbon nanotubes elicits profibrogenic cellular responses that correlate with fibrogenesis biomarkers and fibrosis in the murine lung. ACS Nano (2011) 1.74
KAP1, a novel substrate for PIKK family members, colocalizes with numerous damage response factors at DNA lesions. Cancer Res (2006) 1.72
Acute pulmonary dose-responses to inhaled multi-walled carbon nanotubes. Nanotoxicology (2012) 1.70
Titanium dioxide nanoparticles: a review of current toxicological data. Part Fibre Toxicol (2013) 1.67
Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: role of particle surface area. Part Fibre Toxicol (2008) 1.66
Meeting report: hazard assessment for nanoparticles--report from an interdisciplinary workshop. Environ Health Perspect (2007) 1.64
Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response metrics. J Toxicol Environ Health A (2010) 1.61
In situ-synthesized novel microarray optimized for mouse stem cell and early developmental expression profiling. Genome Res (2003) 1.58
Pulmonary nanoparticle exposure disrupts systemic microvascular nitric oxide signaling. Toxicol Sci (2009) 1.55
Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma. Clin Cancer Res (2006) 1.55
Respiratory toxicologic pathology of inhaled diacetyl in sprague-dawley rats. Toxicol Pathol (2008) 1.54
Time course for inhibition of lipopolysaccharide-induced lung injury by genistein: relationship to alteration in nuclear factor-kappaB activity and inflammatory agents. Crit Care Med (2003) 1.52
Interlaboratory evaluation of rodent pulmonary responses to engineered nanomaterials: the NIEHS Nano GO Consortium. Environ Health Perspect (2013) 1.52
Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2. Cancer Res (2012) 1.50
Cerium oxide nanoparticle-induced pulmonary inflammation and alveolar macrophage functional change in rats. Nanotoxicology (2010) 1.50
Confirmation of gene expression-based prediction of survival in non-small cell lung cancer. Clin Cancer Res (2008) 1.49
Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction. Part Fibre Toxicol (2008) 1.49
Top3β is an RNA topoisomerase that works with fragile X syndrome protein to promote synapse formation. Nat Neurosci (2013) 1.46
Direct fibrogenic effects of dispersed single-walled carbon nanotubes on human lung fibroblasts. J Toxicol Environ Health A (2010) 1.45
Sharpening the focus on occupational safety and health in nanotechnology. Scand J Work Environ Health (2008) 1.44
An in vivo and in vitro toxicological characterisation of realistic nanoscale CeO₂ inhalation exposures. Nanotoxicology (2012) 1.43
Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part Fibre Toxicol (2009) 1.41
Raw single-wall carbon nanotubes induce oxidative stress and activate MAPKs, AP-1, NF-kappaB, and Akt in normal and malignant human mesothelial cells. Environ Health Perspect (2008) 1.40
Predicting cancer drug response by proteomic profiling. Clin Cancer Res (2006) 1.39
Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem (2005) 1.39
Functional analysis of KAP1 genomic recruitment. Mol Cell Biol (2011) 1.39
Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies. Part Fibre Toxicol (2010) 1.38
Single-walled carbon nanotubes: geno- and cytotoxic effects in lung fibroblast V79 cells. J Toxicol Environ Health A (2007) 1.37
Cadmium increases HIF-1 and VEGF expression through ROS, ERK, and AKT signaling pathways and induces malignant transformation of human bronchial epithelial cells. Toxicol Sci (2011) 1.34
Distribution and fibrotic response following inhalation exposure to multi-walled carbon nanotubes. Part Fibre Toxicol (2013) 1.33
Carbon nanotube dosimetry: from workplace exposure assessment to inhalation toxicology. Part Fibre Toxicol (2013) 1.33
Structural insights into human KAP1 PHD finger-bromodomain and its role in gene silencing. Nat Struct Mol Biol (2008) 1.32
Respiratory and olfactory cytotoxicity of inhaled 2,3-pentanedione in Sprague-Dawley rats. Am J Pathol (2012) 1.30
Extrapulmonary transport of MWCNT following inhalation exposure. Part Fibre Toxicol (2013) 1.29
Occupational toxicology of nickel and nickel compounds. J Environ Pathol Toxicol Oncol (2009) 1.27
Design, construction, and characterization of a novel robotic welding fume generator and inhalation exposure system for laboratory animals. J Occup Environ Hyg (2006) 1.26
Assembly, verification, and initial annotation of the NIA mouse 7.4K cDNA clone set. Genome Res (2002) 1.25
The ATM substrate KAP1 controls DNA repair in heterochromatin: regulation by HP1 proteins and serine 473/824 phosphorylation. Mol Cancer Res (2011) 1.23
Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers. Nano Lett (2009) 1.22
Antioxidant properties of fruit and vegetable juices: more to the story than ascorbic acid. Ann Clin Lab Sci (2002) 1.22
Aerosolization of single-walled carbon nanotubes for an inhalation study. Inhal Toxicol (2008) 1.19
Digital sorting of complex tissues for cell type-specific gene expression profiles. BMC Bioinformatics (2013) 1.18
Synthesis, molecular modeling and biological evaluation of chalcone thiosemicarbazide derivatives as novel anticancer agents. Eur J Med Chem (2011) 1.18
Potential role of apoptotic macrophages in pulmonary inflammation and fibrosis. J Cell Physiol (2003) 1.17
Hybrid models identified a 12-gene signature for lung cancer prognosis and chemoresponse prediction. PLoS One (2010) 1.17
Mechanisms of action of inhaled fibers, particles and nanoparticles in lung and cardiovascular diseases. Part Fibre Toxicol (2007) 1.17
Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis. Clin Cancer Res (2010) 1.16
The NIA cDNA project in mouse stem cells and early embryos. C R Biol (2004) 1.16
Induction of pulmonary fibrosis by cerium oxide nanoparticles. Toxicol Appl Pharmacol (2012) 1.16
Differential mouse pulmonary dose and time course responses to titanium dioxide nanospheres and nanobelts. Toxicol Sci (2012) 1.15
Phosphatidylinositol-3-kinase/akt regulates bleomycin-induced fibroblast proliferation and collagen production. Am J Respir Cell Mol Biol (2009) 1.14
A KLF4-miRNA-206 autoregulatory feedback loop can promote or inhibit protein translation depending upon cell context. Mol Cell Biol (2011) 1.13
Multi-walled carbon nanotubes: sampling criteria and aerosol characterization. Inhal Toxicol (2012) 1.13
Toxicology of nanomaterials used in nanomedicine. J Toxicol Environ Health B Crit Rev (2011) 1.13
Progression of lung inflammation and damage in rats after cessation of silica inhalation. Toxicol Sci (2004) 1.12
Impairment of coronary arteriolar endothelium-dependent dilation after multi-walled carbon nanotube inhalation: a time-course study. Int J Mol Sci (2012) 1.12
Generation of mouse ES cell lines engineered for the forced induction of transcription factors. Sci Rep (2011) 1.11
Role of oxidative/nitrosative stress-mediated Bcl-2 regulation in apoptosis and malignant transformation. Ann N Y Acad Sci (2010) 1.11
Vitamin E deficiency enhances pulmonary inflammatory response and oxidative stress induced by single-walled carbon nanotubes in C57BL/6 mice. Toxicol Appl Pharmacol (2007) 1.11
The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2. Biomaterials (2012) 1.11
Nanotoxicology--a pathologist's perspective. Toxicol Pathol (2010) 1.10
Carbon nanotubes induce malignant transformation and tumorigenesis of human lung epithelial cells. Nano Lett (2011) 1.09
Ultraviolet-induced phosphorylation of p70(S6K) at Thr(389) and Thr(421)/Ser(424) involves hydrogen peroxide and mammalian target of rapamycin but not Akt and atypical protein kinase C. Cancer Res (2002) 1.09
Titanium dioxide (TiO2) nanoparticles induce JB6 cell apoptosis through activation of the caspase-8/Bid and mitochondrial pathways. J Toxicol Environ Health A (2009) 1.09
Systematic repression of transcription factors reveals limited patterns of gene expression changes in ES cells. Sci Rep (2013) 1.08
Nanoparticles-containing spray can aerosol: characterization, exposure assessment, and generator design. Inhal Toxicol (2010) 1.07
Potential pulmonary effects of engineered carbon nanotubes: in vitro genotoxic effects. Nanotoxicology (2010) 1.07
Association of arsenic exposure with lung cancer incidence rates in the United States. PLoS One (2011) 1.07
The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticles. Part Fibre Toxicol (2009) 1.06
Metallic nickel nano- and fine particles induce JB6 cell apoptosis through a caspase-8/AIF mediated cytochrome c-independent pathway. J Nanobiotechnology (2009) 1.04
Nitric oxide and reactive oxygen species production causes progressive damage in rats after cessation of silica inhalation. Toxicol Sci (2005) 1.04
Epigenetic gene silencing by the SRY protein is mediated by a KRAB-O protein that recruits the KAP1 co-repressor machinery. J Biol Chem (2009) 1.03